These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis. Davenport A; Fernando RL; Varghese Z Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821 [TBL] [Abstract][Full Text] [Related]
25. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Topley N; Williams JD Kidney Int Suppl; 1994 Dec; 48():S71-8. PubMed ID: 7700045 [No Abstract] [Full Text] [Related]
26. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs. Gewirtz DA; Di X; Walker TD; Sawyer ST Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039 [TBL] [Abstract][Full Text] [Related]
27. Peritonitis - does peritoneal dialysis modality make a difference? Piraino B; Sheth H Blood Purif; 2010; 29(2):145-9. PubMed ID: 20093820 [TBL] [Abstract][Full Text] [Related]
28. Immunologic patterns in CAPD patients with peritonitis. Lamperi S; Carozzi S Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960 [TBL] [Abstract][Full Text] [Related]
29. Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis. Wideröe TE; Sanengen T; Halvorsen S Kidney Int Suppl; 1983 Dec; 16():S208-17. PubMed ID: 6588251 [TBL] [Abstract][Full Text] [Related]
30. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency. Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613 [TBL] [Abstract][Full Text] [Related]
32. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related]
33. Apoptosis and clonogenic cell death in PC3 human prostate cancer cells after treatment with gamma radiation and suramin. Palayoor ST; Bump EA; Teicher BA; Coleman CN Radiat Res; 1997 Aug; 148(2):105-14. PubMed ID: 9254728 [TBL] [Abstract][Full Text] [Related]
34. Murine antigen-induced inflammation--a model for studying induction, resolution and the adaptive phase of inflammation. Tomasdottir V; Vikingsson A; Hardardottir I; Freysdottir J J Immunol Methods; 2014 Dec; 415():36-45. PubMed ID: 25268546 [TBL] [Abstract][Full Text] [Related]
35. Adequacy of chronic peritoneal dialysis in low socioeconomic class uremic children. Muñoz-Arizpe R; Salazar-Gutierrez ML; Gordillo-Paniagua G Int J Pediatr Nephrol; 1986; 7(2):81-4. PubMed ID: 3721729 [TBL] [Abstract][Full Text] [Related]
36. [The present and future of continuous ambulatory peritoneal dialysis (CAPD)]. Selgas R Gac Med Mex; 1993; 129(4):267-71. PubMed ID: 7926414 [TBL] [Abstract][Full Text] [Related]
37. Inflammation amplifies the antitumor cytostasis by human peritoneal macrophages. Ben-Efraim S; Tak C; Fieren MJ; Van den Bemd GJ; Bonta IL Med Oncol Tumor Pharmacother; 1991; 8(2):87-94. PubMed ID: 1749305 [TBL] [Abstract][Full Text] [Related]
38. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis. Rashid G; Korzets Z; Bernheim J Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750 [TBL] [Abstract][Full Text] [Related]
40. Therapeutical effect of activated human macrophages on a human tumor line growing in nude mice. Ben-Efraim S; Tak C; Romijn JC; Fieren MJ; Bonta IL Med Oncol; 1994; 11(1):7-12. PubMed ID: 7921926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]